News

Daeth 80 o weithwyr proffesiynol ym maes iechyd a gofal cymdeithasol a phobl sydd wedi eu heffeithio gan glefyd Parkinson ynghyd yng Nghaerdydd ar 23 Ionawr ar gyfer cyfarfod cyntaf o Rwydwaith Rhagoriaeth Cymru Gyfan.

80 health and social care professionals and people affected by Parkinson’s came together in Cardiff on January 23 for the first All Wales Excellence Network meeting.

Results from a one-year project, funded through the Parkinson’s Virtual Biotech, suggest that NLX-112 has potential as a future treatment for reducing dyskinesia and improving movement symptoms of Parkinson’s.

The latest news on the Sinemet supply.

Herantis Pharma has published initial results from a phase 1/2 study of an experimental protective protein called CDNF which may hold potential to slow, stop or reverse Parkinson's.

We're developing a new support service, Parkinson’s Connect. It will recognise the different ways people want to access help, whether online or in person. It will be available for people with Parkinson’s. As well as their family, friends, and carers.

GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson’s. We take a look at where we are 1 year later.

Over the next few months we plan to share who we are and what we’re doing for the charity. We hope you’ll get to know us better and we’ll know more about you.

A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.

Parkinson's UK volunteer and Belfast athlete, Patrick Crossan, features on the BBC News website in a really positive article focusing on his running successes whilst managing Parkinson's. We hope that there are many more medals to come Patrick.

What you need to know about medicine supply, NHS services and reciprocal healthcare as the UK leaves the EU on 31 January 2020.